Canine Pyelonephritis Study Guide

Overview and Clinical Importance

Pyelonephritis is a bacterial infection of the renal pelvis and parenchyma, representing a significant upper urinary tract infection (UTI) in dogs. It is an important cause of acute kidney injury (AKI) and acute-on-chronic kidney disease. The condition is more common in middle-aged to older dogs, with females being overrepresented. Escherichia coli is the most commonly isolated pathogen, accounting for greater than 50% of cases.

Pyelonephritis typically results from ascending infection from the lower urinary tract, though hematogenous spread can occur rarely. The infection can be acute, causing sudden kidney injury, or chronic, leading to progressive renal damage and potential renal failure. Without early diagnosis and appropriate treatment, pyelonephritis can progress to sepsis, permanent kidney damage, and death.

Relevant Anatomy

The canine kidney is a bean-shaped, retroperitoneal organ located in the dorsal abdomen beneath the sublumbar muscles. The kidney consists of an outer cortex (containing glomeruli and convoluted tubules) and an inner medulla (containing loops of Henle and collecting ducts). The medulla projects into the renal pelvis as the renal crest.

The renal pelvis is a funnel-shaped structure that receives urine from the collecting ducts and channels it into the ureter. In dogs, the renal pelvis has an elongated shape in the craniocaudal direction with 9-17 renal recesses (diverticula) extending into the parenchyma. This anatomical arrangement is important because pyelonephritis specifically involves inflammation of the renal pelvis and adjacent parenchyma.

Etiology and Pathophysiology

Routes of Infection

Ascending infection is the most common route, occurring when bacteria colonize the lower urinary tract and migrate through the ureters to the renal pelvis. Normal host defenses against ascending infection include mucosal defense barriers, ureteral peristalsis, ureterovesical flap valves, and extensive renal blood supply. When these defenses are compromised, bacteria can ascend and establish infection.

Hematogenous spread is much less common but can occur secondary to bacterial endocarditis, diskospondylitis, abscesses, or dental disease. This route typically requires pre-existing renal damage or immunocompromise for infection to establish.

Common Bacterial Pathogens

Risk Factors and Predisposing Conditions

Approximately 75% of dogs with pyelonephritis have one or more predisposing conditions. Recognition of these risk factors is essential for NAVLE success.

Clinical Signs

Clinical presentation varies widely from subclinical (no apparent signs) to severe systemic illness. Many dogs with pyelonephritis are asymptomatic or have only subtle signs, making clinical detection challenging.

Acute vs. Chronic Pyelonephritis

Diagnostic Approach

Clinical diagnosis of pyelonephritis is usually presumptive, based on a combination of clinical signs, laboratory findings, positive urine culture, and imaging findings. Definitive diagnosis requires pyelocentesis with positive culture or histopathology, but these invasive procedures are rarely performed clinically.

Laboratory Findings

Diagnostic Imaging

Ultrasound (Preferred Modality)

Abdominal ultrasound is the imaging modality of choice. However, it's important to note that up to 25% of dogs with histologically confirmed pyelonephritis may have normal ultrasonographic findings.

Radiography

Abdominal radiographs have limited sensitivity for pyelonephritis diagnosis but are useful for identifying nephroliths and ureteroliths that may predispose to infection. Kidney size changes (renomegaly or small, irregular kidneys) may be visible. Excretory urography (IVU) may show dilation and blunting of the renal pelvis with lack of filling of collecting diverticula, but ultrasound is preferred.

Treatment

Treatment of pyelonephritis requires prolonged antibiotic therapy based on culture and sensitivity results. Because pyelonephritis is a tissue infection, antibiotic selection must consider tissue penetration, not just urine concentrations.

Antibiotic Selection

Treatment Duration and Monitoring

Current ISCAID (International Society for Companion Animal Infectious Diseases) guidelines recommend 10-14 days of antibiotic therapy for pyelonephritis, though this is based on human medicine data. Historically, 4-6 weeks was recommended, and longer courses (6-8 weeks) may still be necessary for chronic or complicated cases.

Recommended Monitoring Protocol

• Day 5-7 during treatment: Urine culture to confirm bacterial eradication
• Day 3 before end of treatment: Urine culture to rule out superinfection
• 7-10 days post-treatment: Urine culture and urinalysis to confirm cure
• 1, 3, and 6 months post-treatment: Periodic urine cultures to monitor for recurrence

Supportive Care

• IV fluid therapy: Essential for acute pyelonephritis with AKI; continue until azotemia resolves and patient eating/drinking normally
• Address underlying conditions: Control diabetes, treat Cushing's, remove uroliths, correct anatomic defects
• Antiemetics: Maropitant (Cerenia) for vomiting
• Renal diet: Consider if concurrent CKD present

Complications

Pyonephrosis

Pyonephrosis is accumulation of purulent material in the renal pelvis secondary to obstruction, representing a severe complication requiring emergent intervention. On ultrasound, pyonephrosis shows hyperechoic contents filling a dilated renal pelvis, often with a fluid-debris level, distinguishing it from simple hydronephrosis (anechoic contents).

Other Complications

• Sepsis/Bacteremia: Life-threatening systemic infection
• Chronic kidney disease: Progressive irreversible renal damage
• Perinephric abscess: Rare but serious
• Emphysematous pyelonephritis: Gas-producing infection; rare but characteristic ultrasound appearance

Prognosis

Prognosis varies significantly based on underlying conditions, severity, and timeliness of treatment.